Angel Investors Network

    Venture Capital

    VC funding rounds, fund raises, and venture market trends.

    The Denominator Effect Is Real. But It’s Not Your Best Excuse.
    Venture Capital

    The Denominator Effect Is Real. But It’s Not Your Best Excuse.

    Jeff Barnes, MBA··7 min read
    The 150-LP Myth: Why Bigger Outreach Lists Usually Mean Worse Fundraising.
    Venture Capital

    The 150-LP Myth: Why Bigger Outreach Lists Usually Mean Worse Fundraising.

    Jeff Barnes, MBA··6 min read
    Your Fund Thesis Isn’t Differentiated. It’s Just Better-Worded Sameness.
    Venture Capital

    Your Fund Thesis Isn’t Differentiated. It’s Just Better-Worded Sameness.

    Jeff Barnes, MBA··7 min read
    Why “Differentiated Sourcing” Is Not Enough
    Venture Capital

    Why “Differentiated Sourcing” Is Not Enough

    Jeff Barnes, MBA··7 min read
    Why Emerging Managers Keep Leading With Decks Instead of Proof.
    Venture Capital

    Why Emerging Managers Keep Leading With Decks Instead of Proof.

    Jeff Barnes, MBA··7 min read
    The Fundraising Momentum Trap: Why More Meetings Can Make You Look Weaker
    Venture Capital

    The Fundraising Momentum Trap: Why More Meetings Can Make You Look Weaker

    Jeff Barnes, MBA··8 min read
    Fundraising Timelines Got Longer. Lazy Operators Just Got Exposed.
    Venture Capital

    Fundraising Timelines Got Longer. Lazy Operators Just Got Exposed.

    Jeff Barnes, MBA··7 min read
    The Private Markets Circulatory Problem Is Creating a Huge Opening for Prepared Managers.
    Venture Capital

    The Private Markets Circulatory Problem Is Creating a Huge Opening for Prepared Managers.

    Jeff Barnes, MBA··7 min read
    Reach Capital's $265 Million Fund V: What Patient Capital Is Really Betting On
    Venture Capital

    Reach Capital's $265 Million Fund V: What Patient Capital Is Really Betting On

    Jeff Barnes, MBA··10 min read
    What LPs Hear When You Say “We’re Still Institutionalizing”.
    Venture Capital

    What LPs Hear When You Say “We’re Still Institutionalizing”.

    Jeff Barnes, MBA··7 min read
    The Emerging Manager Advantage Nobody Talks About: Fewer Legacy Excuses.
    Venture Capital

    The Emerging Manager Advantage Nobody Talks About: Fewer Legacy Excuses.

    Jeff Barnes, MBA··7 min read
    Your First 20 LP Targets Should Be Ranked by Fit, Not Fame.
    Venture Capital

    Your First 20 LP Targets Should Be Ranked by Fit, Not Fame.

    Jeff Barnes, MBA··9 min read